XML 17 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statement of Changes in Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Total Shareholders' Equity
Total Shareholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit and Cumulative Distributions
Accumulated Deficit and Cumulative Distributions
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interests
Non-controlling Interests
Cumulative Effect, Period of Adoption, Adjustment
Total Equity, Excluding Redeemable Non Controlling Interest
Total Equity, Excluding Redeemable Non Controlling Interest
Cumulative Effect, Period of Adoption, Adjustment
Class I Common Shares
Common Stock
Class D Common Shares
Common Stock
Class S Common Shares
Common Stock
Beginning balance at Dec. 31, 2022 $ 1,029,650 $ (7,157) $ 736,083 $ (5,162)   $ 744,852 $ 3,678 $ (13,212) $ (5,162) $ 293,567 $ (1,995) $ 1,029,650 $ (7,157) $ 317 $ 14 $ 434
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued     891,563     890,692           891,563   502 26 343
Offering costs     (27,460)     (27,460)           (27,460)        
Distribution reinvestment     26,723     26,697           26,723   11 1 14
Common share repurchases     (31,820)   $ (31,820) (31,789)           (31,820)   (17) (2) (12)
Amortization of restricted stock grants     111     111           111        
Net (loss) income 2,267   363         363   1,972   2,335        
Other comprehensive income 25,612   21,594       21,594     3,941   25,535        
Distributions declared on common shares     (62,820)         (62,820)       (62,820)        
Redeemable common share measurement adjustment     (269)     (269)           (269)        
Contributions from non-controlling interests                   92   92        
Distributions to and redemptions of non-controlling interests                   (36,523)   (36,523)        
Redeemable non-controlling interests measurement adjustment     (346)     (346)           (346)        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership     (4,677)     (4,677)       4,595   (82)        
Ending balance at Sep. 30, 2023 1,809,532   1,543,883     1,597,811 25,272 (80,831)   265,649   1,809,532   813 39 779
Beginning balance at Jun. 30, 2023     1,286,215     1,298,867 23,190 (37,172)   271,815   1,558,030   643 33 654
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Common shares issued     308,631     308,330           308,631   173 5 123
Offering costs     (6,826)     (6,826)           (6,826)        
Distribution reinvestment     11,329     11,317           11,329   5 1 6
Common share repurchases     (12,477)   $ (12,477) (12,465)           (12,477)   (8)   (4)
Amortization of restricted stock grants     37     37           37        
Net (loss) income (20,651)   (17,793)         (17,793)   (2,726)   (20,519)        
Other comprehensive income 2,438   2,082       2,082     355   2,437        
Distributions declared on common shares     (25,866)         (25,866)       (25,866)        
Redeemable common share measurement adjustment     (127)     (127)           (127)        
Contributions from non-controlling interests                   33   33        
Distributions to and redemptions of non-controlling interests                   (4,781)   (4,781)        
Redeemable non-controlling interests measurement adjustment     (341)     (341)           (341)        
Reallocation between additional paid-in capital and non-controlling interests due to changes in ownership     (981)     (981)       953   (28)        
Ending balance at Sep. 30, 2023 $ 1,809,532   $ 1,543,883     $ 1,597,811 $ 25,272 $ (80,831)   $ 265,649   $ 1,809,532   $ 813 $ 39 $ 779